Literature DB >> 16118319

First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation.

Christopher J Fraser1, Betsy A Hirsch, Vanessa Dayton, Michael H Creer, Joseph P Neglia, John E Wagner, K Scott Baker.   

Abstract

Donor cell leukemia is a rare complication after allogeneic hematopoietic stem cell transplantation. A 12-month-old boy underwent unrelated donor umbilical cord blood transplant (UCBT) for refractory Langerhan's cell histiocytosis. Forty months after transplantation, he developed acute myeloid leukemia. Cytogenetic and molecular analysis confirmed donor cell origin. The Cord Blood Bank (CBB) contacted the donor's family and established that the child, now 7 years old, was healthy. This represents the first reported case of donor cell leukemia following UCBT. This case illustrates that donor cell leukemia is a rare but real event after UCBT as with other stem cell sources and highlights the need for CBBs to maintain linkage data between donors and recipients.

Entities:  

Mesh:

Year:  2005        PMID: 16118319      PMCID: PMC1895243          DOI: 10.1182/blood-2005-06-2551

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Outcomes of a program to evaluate mother and baby 6 months after umbilical cord blood donation.

Authors:  L Lecchi; P Rebulla; I Ratti; M Magri; F Garcea; F Marangoni; T Bertelé; R Giordano; G Sirchia
Journal:  Transfusion       Date:  2001-05       Impact factor: 3.157

2.  Concurrent Langerhans cell histiocytosis and myelodysplasia in children.

Authors:  G Surico; P Muggeo; N Rigillo; H Gadner
Journal:  Med Pediatr Oncol       Date:  2000-10

Review 3.  B-cell lymphoma developing in the donor 9 years after donor-origin acute myeloid leukemia post bone marrow transplantation.

Authors:  B Bielorai; H J Deeg; M Weintraub; Y Neumann; E Rosner; N Amariglio; G Rechavi; A Toren
Journal:  Bone Marrow Transplant       Date:  2003-05       Impact factor: 5.483

4.  The cord-blood-bank controversies.

Authors:  Robert Steinbrook
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

Review 5.  Malignancies after hematopoietic stem cell transplantation: many questions, some answers.

Authors:  H J Deeg; G Socie
Journal:  Blood       Date:  1998-03-15       Impact factor: 22.113

6.  The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society.

Authors:  R M Egeler; J P Neglia; M Aricò; B E Favara; A Heitger; M E Nesbit; H S Nicholson
Journal:  Hematol Oncol Clin North Am       Date:  1998-04       Impact factor: 3.722

7.  A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase.

Authors:  Y Saito; Y Uzuka; N Sakai; S Suzuki; T Toyota
Journal:  Bone Marrow Transplant       Date:  2000-06       Impact factor: 5.483

8.  Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots.

Authors:  K B Gale; A M Ford; R Repp; A Borkhardt; C Keller; O B Eden; M F Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

Review 9.  Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature.

Authors:  L D Cooley; D A Sears; M M Udden; W R Harrison; K R Baker
Journal:  Am J Hematol       Date:  2000-01       Impact factor: 10.047

10.  Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers.

Authors:  S J Scharf; A G Smith; J A Hansen; C McFarland; H A Erlich
Journal:  Blood       Date:  1995-04-01       Impact factor: 22.113

View more
  22 in total

1.  Cell fate control gene therapy based on engineered variants of human deoxycytidine kinase.

Authors:  Anton Neschadim; James C M Wang; Takeya Sato; Daniel H Fowler; Arnon Lavie; Jeffrey A Medin
Journal:  Mol Ther       Date:  2012-01-24       Impact factor: 11.454

2.  Donor-derived second hematologic malignancies after cord blood transplantation.

Authors:  Karen K Ballen; Corey Cutler; Beow Y Yeap; Steven L McAfee; Bimalangshu R Dey; Eyal C Attar; Yi-Bin Chen; Richard L Haspel; Deborah Liney; John Koreth; Vincent Ho; Edwin P Alyea; Robert J Soiffer; Thomas R Spitzer; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-21       Impact factor: 5.742

3.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

Authors:  Lindsay M Morton; Wael Saber; K Scott Baker; A John Barrett; Smita Bhatia; Eric A Engels; Shahinaz M Gadalla; David E Kleiner; Steven Pavletic; Linda J Burns
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-12       Impact factor: 5.742

4.  Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges.

Authors:  Nirali N Shah; Ulrike Bacher; Terry Fry; Katherine R Calvo; Maryalice Stetler-Stevenson; Diane C Arthur; Roger Kurlander; Kristin Baird; Barbara Wise; Sergio Giralt; Michael Bishop; Nancy M Hardy; Alan S Wayne
Journal:  Am J Hematol       Date:  2012-04-04       Impact factor: 10.047

Review 5.  Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source.

Authors:  H Shiozaki; K Yoshinaga; T Kondo; Y Imai; M Shiseki; N Mori; M Teramura; T Motoji
Journal:  Bone Marrow Transplant       Date:  2013-09-09       Impact factor: 5.483

Review 6.  Donor cell leukemia in umbilical cord blood transplant patients: a case study and literature review highlighting the importance of molecular engraftment analysis.

Authors:  Jennifer Crow; Kenneth Youens; Susan Michalowski; Gail Perrine; Cassandra Emhart; Felicia Johnson; Amy Gerling; Joanne Kurtzberg; Barbara K Goodman; Siby Sebastian; Catherine W Rehder; Michael B Datto
Journal:  J Mol Diagn       Date:  2010-04-29       Impact factor: 5.568

7.  Post-Transplantation Cyclophosphamide after Bone Marrow Transplantation Is Not Associated with an Increased Risk of Donor-Derived Malignancy.

Authors:  Robbie G Majzner; Huzefa Mogri; Ravi Varadhan; Patrick Brown; Kenneth R Cooke; Javier Bolaños-Meade; Lode Swinnen; Jennifer Kanakry; Leo Luznik; Richard J Jones; Ephraim Fuchs; Rich Ambinder; Yvette Kasamon; Heather J Symons
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-03       Impact factor: 5.742

8.  Donor cell-derived chronic myeloproliferative disease with t(7;11)(p15;p15) after cord blood transplantation in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Hideki Mitsui; Tsuyoshi Nakazawa; Akira Tanimura; Takahiro Karasuno; Akira Hiraoka
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

9.  Spontaneous cell fusion of acute leukemia cells and macrophages observed in cells with leukemic potential.

Authors:  Ines Martin-Padura; Paola Marighetti; Giuliana Gregato; Alice Agliano; Omar Malazzi; Patrizia Mancuso; Giancarlo Pruneri; Andrea Viale; Francesco Bertolini
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

10.  Donor cell-derived acute lymphocytic leukemia after allogeneic stem cell transplantation for multiple myeloma.

Authors:  Natsue Igarashi; Takaaki Chou; Takayuki Hirose; Yousuke Imai; Takuro Ishiguro; Keiichi Nemoto
Journal:  Int J Hematol       Date:  2009-08-20       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.